News & Analysis on Clinical Trial Services & Contract Research And Development
Canada-headquartered contract manufacturing company Patheon is now offering the largest capacity in Europe for lyophilisation, following the completion of a €60 million investment programme at its facilities in Monza and Ferentino in Italy.
Germany's Merck KGaA has almost completed the construction of a €200 million plant that will provide a significant increase in the company's organic synthesis business.
Misssouri-based medical genomics company GenoMed will link up with Malaysian company PhenoMed, encouraged by the Malaysian government currently keen to push biotechnology advances in the country.
Nordic pharmaceutical company Pharmaco forges further into Northern Europe unveiling new sales activities in Sweden to cut into the growing generic pharmaceutical market there.
Danish chemical group Novo Nordisk will likely deliver a 'lacklustre' set of results for the first nine months of the year but strong enough to put the company on track to deliver its guidance of 'low single-digit EBIT growth' on a reported basis for...